Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung CancerKohsuke Isomoto, Kazuhiko Nakagawa, Tadashi Ishida et al.|Clinical Cancer Research|2020Cited by 244
Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with NivolumabJunko Tanizaki, Kazuhiko Nakagawa, Koji Haratani et al.|Journal of Thoracic Oncology|2017Cited by 227
Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancerHisato Kawakami, Kazuhiko Nakagawa, Junko Tanizaki et al.|Investigational New Drugs|2017Cited by 170
The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancerHidetoshi Hayashi, Kazuto Nishio, Tokuzo Arao et al.|Oncogene|2013Cited by 143
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid TumorsMasayuki Takeda, Kazuto Nishio, Takayuki Takahama et al.|The Oncologist|2020Cited by 95